Concentration of Risk

AMGEN INC

High

AMGN · Nasdaq · Biological Products, (No Diagnostic Substances) · CIK 0000318154

Latest filing: 10-K · 2026-02-13

Customer concentration

Significant Customers note · revenue dependency

High
Top exposure
77%
Three Customers
Customer One27%
Customer Two34%
Customer Three16%
Members of this group
Flat

Click a point to open the SEC source

FY250%20%40%60%80%

Geographic concentration

Segment reporting · geographic revenue

High
Top exposure
71.9%
U.S
Flat

Click a point to open the SEC source

FY23FY24FY250%20%40%60%80%

Supplier concentration

Risk Factors · supply chain dependency

Low
Dependency
Diversified
Diversified
Flat

Qualitative dependency level by filing year.

Product concentration

ASC 275 · disclosed dependence on a specific product or service

Low
Top exposure
<10%
No disclosure detected
Flat

Credit concentration

ASC 825 · concentration of credit risk note

High
Receivables
75%
Three Customers
+5.0pp YoY

Click a point to open the SEC source

FY24FY250%20%40%60%80%